ClinicalThought

Share

Program Content

Activities

  • CDK4,6 Inhibitors in Breast Cancer
    Experts Answer Your Questions on CDK4/6 Inhibitors in HR+/HER2- Breast Cancer
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 05, 2024

    Expires: July 04, 2025

  • Inhibiteurs de CDK4/6 dans le cancer du sein HR+/HER2-
    Des experts répondent à vos questions concernant les inhibiteurs de CDK4/6 dans le cancer du sein HR+/HER2-
    PDF
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 09, 2024

    Expires: August 08, 2025

  • Inibidores de CDK4/6 no câncer de mama HR+/HER2-
    Especialistas respondem às suas perguntas sobre inibidores de CDK4/6 no câncer de mama HR+/HER2-
    PDF
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 19, 2024

    Expires: August 18, 2025

  • Los inhibidores de CDK4/6 en el cáncer de mama RH+/HER2-
    Los expertos responden a sus preguntas sobre los inhibidores de CDK4/6 en el cáncer de mama RH+/HER2-
    PDF
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 21, 2024

    Expires: August 20, 2025

Provided by

ProCE Banner

Supporters

Supported by educational grants from Lilly and Novartis Pharmaceuticals Corporation.

Lilly

Novartis Pharmaceuticals Corporation